Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Zogenix stock in Canada | $17.58
Own Zogenix shares in just a few minutes.
Zogenix is a biotechnology business based in the US. Zogenix stocks (ZGNX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $17.65 – a decrease of 5.64% over the previous week. Zogenix employs 218 staff and has a trailing 12-month revenue of around $26.1 million.
How to buy Zogenix stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ZGNX in this case.
- Research Zogenix stocks. The platform should provide the latest information available.
- Buy your Zogenix stocks. It's that simple.
What's in this guide?
- Can I buy shares in Zogenix?
- Has coronavirus impacted Zogenix shares?
- Zogenix shares summary
- Compare share dealing platforms
- Is Zogenix stock a buy or sell?
- Zogenix performance over time
- Can I short Zogenix shares?
- Zogenix's financials
- How volatile are Zogenix shares?
- Does Zogenix pay a dividend?
- Have Zogenix shares ever split?
- Other common questions
How has Coronavirus impacted Zogenix's stock price?
Since the stock market crash in March caused by coronavirus, Zogenix's stock price has had significant negative movement.
Its last market close was $17.58, which is 41.71% down on its pre-crash value of $30.16 and 5.59% up on the lowest point reached during the March crash when the stocks fell as low as $16.65.
If you had bought $1,000 worth of Zogenix stocks at the start of February 2020, those stocks would have been worth $407.11 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $348.61.
Zogenix stock priceUse our graph to track the performance of ZGNX stocks over time.
Zogenix stocks at a glance
|Latest market close||$17.58|
|52-week range||$15.9 - $25.88|
|50-day moving average||$17.5721|
|200-day moving average||$19.0893|
|Wall St. target price||$48.22|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.32|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Zogenix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Zogenix price performance over time
|1 month (2021-07-02)||-0.90%|
|3 months (2021-04-30)||-6.93%|
|Revenue TTM||USD$26.1 million|
|Gross profit TTM||USD$-124,901,000|
|Return on assets TTM||-23.82%|
|Return on equity TTM||-61.99%|
|Market capitalisation||USD$904.7 million|
TTM: trailing 12 months
How to short and sell Zogenix stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ZGNX.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 8.0 million Zogenix stocks held short by investors – that's known as Zogenix's "short interest". This figure is 0.6% down from 8.1 million last month.
There are a few different ways that this level of interest in shorting Zogenix stocks can be evaluated.
Zogenix's "short interest ratio" (SIR)
Zogenix's "short interest ratio" (SIR) is the quantity of Zogenix stocks currently shorted divided by the average quantity of Zogenix stocks traded daily (recently around 1.3 million). Zogenix's SIR currently stands at 6.25. In other words for every 100,000 Zogenix stocks traded daily on the market, roughly 6250 stocks are currently held short.
However Zogenix's short interest can also be evaluated against the total number of Zogenix stocks, or, against the total number of tradable Zogenix stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Zogenix's short interest could be expressed as 0.14% of the outstanding stocks (for every 100,000 Zogenix stocks in existence, roughly 140 stocks are currently held short) or 0.1787% of the tradable stocks (for every 100,000 tradable Zogenix stocks, roughly 179 stocks are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the stock price, with fewer people currently willing to bet against Zogenix.
Find out more about how you can short Zogenix stock.
Zogenix stock dividends
We're not expecting Zogenix to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Zogenix stocks ever split?
Zogenix stocks were split on a 1:8 basis on 1 July 2015. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Zogenix stocks – just the quantity. However, indirectly, the new 700% higher stock price could have impacted the market appetite for Zogenix stocks which in turn could have impacted Zogenix's stock price.
Zogenix stock price volatility
Over the last 12 months, Zogenix's stocks have ranged in value from as little as $15.9 up to $25.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Zogenix's is 1.3977. This would suggest that Zogenix's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.
Stocks similar to Zogenix
Zogenix in the news
Zogenix (ZGNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2021 Top Idea Contest - New Ideas
Zogenix to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5
Frequently asked questions
More guides on Finder
How to buy Wheels Up (UP) stock in Canada when it goes public
Everything we know about the Wheels Up IPO, plus information on how to buy in.
How to invest $1 million
Here are the top 5 ways you should invest $1 million.
How to buy Brookfield Asset Management Reinsurance Partners Ltd (BAMR) stock in Canada when it goes public
Everything we know about the Brookfield Asset Management Reinsurance Partners Ltd IPO, plus information on how to buy in.
How to buy Traeger (COOK) stock in Canada when it goes public
Everything we know about the Traeger IPO, plus information on how to buy in.
How to buy Teads (TEAD) stock in Canada when it goes public
Everything we know about the Teads IPO, plus information on how to buy in.
How to buy Snap One Holdings Corp (SNPO) stock in Canada
Everything we know about the Snap One Holdings Corp IPO, plus information on how to buy in.
How to buy Riskified (RSKD) stock in Canada
Everything we know about the Riskified IPO, plus information on how to buy in.
How to buy Preston Hollow Community Capital (PHCC) stock in Canada when it goes public
Everything we know about the Preston Hollow Community Capital IPO, plus information on how to buy in.
How to buy PowerSchool Holdings (PWSC) stock in Canada
Everything we know about the PowerSchool Holdings IPO, plus information on how to buy in.
How to buy MeridianLink (MLNK) stock in Canada
Everything we know about the MeridianLink IPO, plus information on how to buy in.